Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Natural History Study in Patients With Genetically Confirmed Diagnosis of Autosomal Dominant Optic Atrophy (ADOA), Caused by OPA1 Mutation

NCT06140329 is registered in ClinicalTrials.gov with PYC Therapeutics as lead sponsor.

NCT NCT06140329
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06140329 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Natural History Study in Patients With Genetically Confirmed Diagnosis of Autosomal Dominant Optic Atrophy (ADOA), Caused by OPA1 Mutation
Lead sponsor
PYC Therapeutics
Phase
Observational
Overall status
Terminated
Start date
February 28, 2024
Completion date
March 10, 2025
Enrollment
1 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

autosomal dominant optic atrophy, kjer optic atrophy, optic atrophies, hereditary, optic atrophy, autosomal dominant